VectivBio (VECT) Income Statement (2019 - 2023)
Income Statement report data from Mar 31, 2019 to Mar 31, 2023 for VectivBio (VECT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||
Total Revenue | 680K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 680K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||
Research And Development | 112M (+789.16%) | 13M | - | 13M (0.00%) | 13M (0.00%) | 13M (0.00%) | 13M (0.00%) | 13M (+16.64%) | 11M (0.00%) | 11M (0.00%) | 11M (0.00%) | 11M (+169.00%) | 4.00M (0.00%) | 4.00M (0.00%) | 4.00M (0.00%) | 4.00M |
Selling General And Administrative | 7.06M (-21.12%) | 8.95M | - | 8.95M (0.00%) | 8.95M (0.00%) | 8.95M (0.00%) | 8.95M (0.00%) | 8.95M (+155.71%) | 3.50M (0.00%) | 3.50M (0.00%) | 3.50M (0.00%) | 3.50M (+69.90%) | 2.06M (0.00%) | 2.06M (0.00%) | 2.06M (0.00%) | 2.06M |
Operating Expenses | -40.04M | - | - | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (+46.33%) | -14.85M (0.00%) | -14.85M (0.00%) | -14.85M (0.00%) | -14.85M (+153.41%) | -5.86M (0.00%) | -5.86M (0.00%) | -5.86M (0.00%) | -5.86M |
Depreciation And Amortization | -90.00K | 30K | - | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (+50.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K |
Operating Income | ||||||||||||||||
Operating Income | -28.55M (+31.69%) | -21.68M | - | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (+46.33%) | -14.85M (0.00%) | -14.85M (0.00%) | -14.85M (0.00%) | -14.85M (+153.41%) | -5.86M (0.00%) | -5.86M (0.00%) | -5.86M (0.00%) | -5.86M |
Ebit | -28.55M (+31.39%) | -21.73M (+40.56%) | -15.46M (-28.85%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (0.00%) | -21.73M (+46.33%) | -14.85M (0.00%) | -14.85M (0.00%) | -14.85M (0.00%) | -14.85M (+153.41%) | -5.86M (0.00%) | -5.86M (0.00%) | -5.86M (0.00%) | -5.86M |
EBITDA | -28.64M (+31.98%) | -21.70M | - | -21.70M (0.00%) | -21.70M (0.00%) | -21.70M (0.00%) | -21.70M (0.00%) | -21.70M (+46.42%) | -14.82M (0.00%) | -14.82M (0.00%) | -14.82M (0.00%) | -14.82M (+153.77%) | -5.84M (0.00%) | -5.84M (0.00%) | -5.84M (0.00%) | -5.84M |
Other Income / Expenses | ||||||||||||||||
Interest Expense | 30K (+200.00%) | 10K | - | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-92.86%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (+1300.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Net Income | ||||||||||||||||
Income Before Tax | -28.53M (+31.23%) | -21.74M | - | -21.74M (0.00%) | -21.74M (0.00%) | -21.74M (0.00%) | -21.74M (0.00%) | -21.74M (+45.03%) | -14.99M (0.00%) | -14.99M (0.00%) | -14.99M (0.00%) | -14.99M (+155.37%) | -5.87M (0.00%) | -5.87M (0.00%) | -5.87M (0.00%) | -5.87M |
Income Tax Expense | -50.00K | 20K (+100.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (-85.71%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (+1300.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Net Income | -28.48M (+30.94%) | -21.75M | - | -21.75M (0.00%) | -21.75M (0.00%) | -21.75M (0.00%) | -21.75M (0.00%) | -21.75M (+43.85%) | -15.12M (0.00%) | -15.12M (0.00%) | -15.12M (0.00%) | -15.12M (+157.14%) | -5.88M (0.00%) | -5.88M (0.00%) | -5.88M (0.00%) | -5.88M |